These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 17081531

  • 1. Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection.
    Smeenk JM, Sweep FC, Zielhuis GA, Kremer JA, Thomas CM, Braat DD.
    Fertil Steril; 2007 Jan; 87(1):223-6. PubMed ID: 17081531
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
    Peñarrubia J, Fábregues F, Manau D, Creus M, Casals G, Casamitjana R, Carmona F, Vanrell JA, Balasch J.
    Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
    [Abstract] [Full Text] [Related]

  • 4. Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center study.
    Polyzos NP, Nelson SM, Stoop D, Nwoye M, Humaidan P, Anckaert E, Devroey P, Tournaye H.
    Fertil Steril; 2013 Aug; 100(2):438-44. PubMed ID: 23602319
    [Abstract] [Full Text] [Related]

  • 5. Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients?
    Muttukrishna S, Suharjono H, McGarrigle H, Sathanandan M.
    BJOG; 2004 Nov; 111(11):1248-53. PubMed ID: 15521870
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
    Elgindy EA, El-Haieg DO, El-Sebaey A.
    Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
    [Abstract] [Full Text] [Related]

  • 11. Anti-mullerian hormone as a marker of ovarian reserve.
    Tremellen KP, Kolo M, Gilmore A, Lekamge DN.
    Aust N Z J Obstet Gynaecol; 2005 Feb; 45(1):20-4. PubMed ID: 15730360
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antimüllerian hormone levels are strongly associated with live-birth rates after assisted reproduction.
    Brodin T, Hadziosmanovic N, Berglund L, Olovsson M, Holte J.
    J Clin Endocrinol Metab; 2013 Mar; 98(3):1107-14. PubMed ID: 23408576
    [Abstract] [Full Text] [Related]

  • 14. Serum antimüllerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle are predictive of the fertilization, implantation, and pregnancy in polycystic ovary syndrome patients undergoing assisted reproduction.
    Kaya C, Pabuccu R, Satıroglu H.
    Fertil Steril; 2010 Nov; 94(6):2202-7. PubMed ID: 20138267
    [Abstract] [Full Text] [Related]

  • 15. An initial low response predicts poor outcome in in vitro fertilization/intracytoplasmic sperm injection despite improved ovarian response in consecutive cycles.
    Veleva Z, Järvelä IY, Nuojua-Huttunen S, Martikainen H, Tapanainen JS.
    Fertil Steril; 2005 May; 83(5):1384-90. PubMed ID: 15866573
    [Abstract] [Full Text] [Related]

  • 16. Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles.
    Ebner T, Sommergruber M, Moser M, Shebl O, Schreier-Lechner E, Tews G.
    Hum Reprod; 2006 Aug; 21(8):2022-6. PubMed ID: 16679324
    [Abstract] [Full Text] [Related]

  • 17. Different serum anti-Müllerian hormone concentrations are associated with oocyte quality, embryo development parameters and IVF-ICSI outcomes.
    Irez T, Ocal P, Guralp O, Cetin M, Aydogan B, Sahmay S.
    Arch Gynecol Obstet; 2011 Nov; 284(5):1295-301. PubMed ID: 21748312
    [Abstract] [Full Text] [Related]

  • 18. Assessment of FSHR variants and antimüllerian hormone in infertility patients with a reduced ovarian response to gonadotropin stimulation.
    Binder H, Strick R, Zaherdoust O, Dittrich R, Hamori M, Beckmann MW, Oppelt PG.
    Fertil Steril; 2012 May; 97(5):1169-75.e1. PubMed ID: 22401810
    [Abstract] [Full Text] [Related]

  • 19. Development of a sensitive enzyme immunoassay for anti-Müllerian hormone and the evaluation of potential clinical applications in males and females.
    Al-Qahtani A, Muttukrishna S, Appasamy M, Johns J, Cranfield M, Visser JA, Themmen AP, Groome NP.
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):267-73. PubMed ID: 16117813
    [Abstract] [Full Text] [Related]

  • 20. Antimüllerian hormone: prediction of cumulative live birth in gonadotropin-releasing hormone antagonist treatment for in vitro fertilization.
    Hamdine O, Eijkemans MJC, Lentjes EGW, Torrance HL, Macklon NS, Fauser BCJM, Broekmans FJ.
    Fertil Steril; 2015 Oct; 104(4):891-898.e2. PubMed ID: 26196233
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.